Pronova BioPharma
1837
FOUNDED
M&A
STATUS
101-200
EMPLOYEES
M&A
LATEST DEAL TYPE
4
FINANCING ROUNDS
Description
Developer lipid therapies. The company develops and manufactures marine originated omega-3 derived pharmaceutical products.
Formerly Known As
Pronova Biocare
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
- Vollsveien 6
- 1366 Oslo
- Norway
+47 22 00 00 00
Pronova BioPharma Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Pronova BioPharma‘s full profile, request access.
Request full access to PitchBookPronova BioPharma Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Pronova BioPharma‘s full profile, request access.
Request full access to PitchBookPronova BioPharma Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Morten Jurs | Chief Executive Officer |
2 Former Executives
You’re viewing 1 of 3 executives. Get the full list »